ClinicalTrials.Veeva

Menu

Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations

U

Universitaire Ziekenhuizen KU Leuven

Status

Withdrawn

Conditions

Platelet Function

Treatments

Other: blood test

Study type

Observational

Funder types

Other

Identifiers

NCT01352923
B322201111373

Details and patient eligibility

About

In this study PEAR1 polymorphisms effects will be analyze in blood platelets to determine how PEAR1 regulates platelet activation.

Full description

Several large-scale studies have confirmed the long held notion that platelet responses to different agonists are highly variable, within well defined populations of healthy donors. Single nucleotide polymorphisms in genes encoding platelet proteins can explain the wide range of responses to standard platelet agonists. Yet, numerous SNPs point towards proteins with previously unknown function in platelets, wich modulate the complex network of signaling events that regulate platelet function and further augment variability. PEAR1 is mainly expressed in platelets and endothelial cells. A few studies have linked SNPs in PEAR1 with decreased or increased platelet responses to various agonists. However, hitherto, no direct functional studies have been carried out to determine whether and how PEAR1 modulate intracellular signaling pathways relevant for platelet function.

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy voluntary donors

Exclusion criteria

  • none

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

peripheral blood
Description:
healthy voluntary donors
Treatment:
Other: blood test

Trial contacts and locations

1

Loading...

Central trial contact

Peter Verhamme; Alexandre Kauskot

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems